BioNexus Gene Lab
(NASDAQ) BGLC
BioNexus Gene Lab Financials at a Glance
Market Cap
$4.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$5.31M
Net Income (TTM)
-$2.90M
EPS (TTM)
-$1.49
P/E Ratio
-1.29
Dividend
$0.00
Beta (Volatility)
0.31 (Low)
Dividend
$0.00
Beta (Volatility)
0.31 (Low)
Price
$1.93
Volume
3,456
Open
$1.93
Price
$1.93
Volume
3,456
Open
$1.93
Previous Close
$1.93
Daily Range
$1.81 - $1.94
52-Week Range
$1.07 - $8.98
Estimated Earnings Date
Apr 14, 2026
Dividend
$0.00
Beta (Volatility)
0.31 (Low)
Price
$1.93
Volume
3,456
Open
$1.93
Previous Close
$1.93
Daily Range
$1.81 - $1.94
52-Week Range
$1.07 - $8.98
Estimated Earnings Date
Apr 14, 2026
BGLC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioNexus Gene Lab
Industry
Trading Companies and Distributors
Sector
IndustrialsEmployees
16
CEO
Su Leng Tan Lee
Website
www.bionexusgenelab.comHeadquarters
Kuala Lumpur, WP 59200, MY
BGLC Financials
Key Financial Metrics (TTM)
Gross Margin
13.54%
Operating Margin
-54.93%
Net Income Margin
-54.70%
Return on Equity
-37.43%
Return on Capital
-35.93%
Return on Assets
-13.70%
Earnings Yield
-77.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
2.42M
Volume
3.46K
Avg. Volume
99.10K
Financials (TTM)
Gross Profit
$718.99K
Operating Income
-$2.92M
EBITDA
-$2.72M
Operating Cash Flow
-$1.16M
Capital Expenditure
-$28.25K
Free Cash Flow
-$1.19M
Cash & ST Invst.
$3.96M
Total Debt
$216.43K
BioNexus Gene Lab Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$22.84K
-98.9%
Gross Profit
-$22.73K
-106.6%
Gross Margin
-99.51%
N/A
Market Cap
$4.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$243.01K
N/A
Employees
19
N/A
Net Income
-$543.58K
+12.8%
EBITDA
-$496.61K
+9.2%
Quarterly Fundamentals
Total Cash
$3.96M
+10.3%
Total Debt
$216.43K
+8.2%
Accounts Receivable
$141.47K
-90.8%
Inventory
$667.15K
-43.4%
Long Term Debt
$150.41K
+1.7%
Short Term Debt
$66.02K
+26.5%
Return on Assets
-13.70%
N/A
Return on Invested Capital
-14.30%
N/A
Free Cash Flow
-$148.00K
+82.2%
Operating Cash Flow
-$147.67K
+82.1%